Tom Beil at the Rx-360 panel discussion
Rx-360 is a global quality consortium with a mission to “protect patient safety by sharing information and developing processes related to the integrity of the healthcare supply chain and the quality of materials within the supply chain”. Comprised of regulators, pharmaceutical executives, supplier executives and other industry figures, Rx-360 members are dedicated to patient safety. The group strongly advocates collaboration for quality to ensure that counterfeit drugs do not enter the market.
Vice President of Quality and Regulatory Affairs at Sigma-Aldrich, and Rx-360 founding board member, Tom Beil is committed to affecting positive change in the pharmaceutical industry. Rx-360 posted an in-depth interview with Tom on this passion, and his experience working with both manufacturers and suppliers to define expectations, identify challenges, and develop a solution for sharing best practices among the industry. In it, he acknowledges that the supply chain is ever evolving and points out that while it is important to recognize what is wrong, the ultimate focus should be on how to make it right. To read the full interview with Tom, click here.
Earlier this year in, Tom participated in a panel discussion at Informex in Anaheim, CA where Rx-360 members joined to examine new ways to improve supply chain security and auditing. The discussion was featured in the June edition of Contract Pharma, and can be found by clicking here.
Tom also hosted a Pharmaceutical Technology webcast on quality with industry colleagues during the month of June. The recap of the webcast may be found by clicking here.
To learn more about Rx-360, or to join, please visit www.rx-360.org